Skip to main content
Clinical Trials/NCT05311982
NCT05311982
Completed
Not Applicable

Transcranial Direct Current Stimulation Modulates Spectral Power and Coherence in Autism Spectrum Disorder: a Triple-blind, Placebo-controlled Study

Federal University of Paraíba2 sites in 1 country12 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autistic Disorders Spectrum
Sponsor
Federal University of Paraíba
Enrollment
12
Locations
2
Primary Endpoint
to compare the effectiveness of Neuromodulation techniques - transcranial direct current stimulation (tDCS) - in the treatment of people with Autism Spectrum Disorder
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

To understand the changes in the resting electroencephalogram (EEG) brain networks of children and adolescents with autistic spectrum disorder (ASD) induced by transcranial direct current stimulation (tDCS), we asked two questions. First: how can tDCS modulate the expression of neural network dynamics? Second: how can tDCS modulate functional connections at specific frequencies? We hypothesized that the tDCS mechanism results in increased cortical frequencies in the areas under the anode, which may reflect an increase in synaptic connectivity, and that this tDCS-related increase changes connection profiles at specific frequencies important for ASD, indicating improvement in symptoms. To verify this improvement, the researchers used the Autism Treatment Evaluation Checklist (ATEC) after an intervention, comparing baseline scores with post-treatment scores.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
September 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Federal University of Paraíba
Responsible Party
Principal Investigator
Principal Investigator

Suellen Marinho Andrade

Principal Investigator

Federal University of Paraíba

Eligibility Criteria

Inclusion Criteria

  • Patients with ASD reported by a Neuropediatrician; Age group between 5 and 18 years; Mild and moderate clinical symptoms

Exclusion Criteria

  • Patients with severe mental illness; Use of a pacemaker or other metal device on the body; Brain tumor or intracranial infection; Uncooperative parents or caregivers; Epilepsy; structural change in the skull

Outcomes

Primary Outcomes

to compare the effectiveness of Neuromodulation techniques - transcranial direct current stimulation (tDCS) - in the treatment of people with Autism Spectrum Disorder

Time Frame: 7 weeks

EEG and TDCS

Secondary Outcomes

  • Check the effects of tDCS modulations on cognitive responses through Autism Treatment Evaluation Checklist(7 weeks)

Study Sites (2)

Loading locations...

Similar Trials